These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4899641)

  • 1. Experimental pyelonephritis. XV. Increased susceptibility to E. coli infection in old rats.
    Freeman LR
    Yale J Biol Med; 1969 Aug; 42(1):30-8. PubMed ID: 4899641
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental pyelonephritis in the cat. 1. Gross and histological changes.
    Kelly DF; Lucke VM; McCullagh KG
    J Comp Pathol; 1979 Jan; 89(1):125-39. PubMed ID: 370162
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of in vitro induced microbial L-forms in experimental hematogenous pyelonephritis.
    Ponig B; Domingue G; Schlegel J
    Invest Urol; 1972 Jan; 9(4):282-5. PubMed ID: 4550878
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental ascending Escherichia coli pyelonephritis in the rat.
    Prát V; Losse H; Konícková L; Ritzerfeldd W
    Invest Urol; 1970 Nov; 8(3):311-8. PubMed ID: 4922389
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the bacteriological findings in the urine and in the kidney in experimental E. coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W
    Cas Lek Cesk; 1969 May; 108(23):701-4. PubMed ID: 4891729
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental pyelonephritis in primates.
    Schoonees R; Neter E; Murphy GP
    J Med; 1972; 3(6):363-72. PubMed ID: 4203808
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyelonephritis XV. Long-term study of ascending Escherichia coli pyelonephritis in mice.
    Kalmanson GM; Montgomerie JZ; Hubert EG; Barajas L; Guze LB
    Yale J Biol Med; 1973 Jun; 46(3):196-202. PubMed ID: 4611056
    [No Abstract]   [Full Text] [Related]  

  • 8. Haemolytic Escherichia coli in etiopathogenesis of pyelonephritis in rats--an experimental study.
    Akulwar SL; Kurhade AM; Saoji AM
    Indian J Pathol Microbiol; 1997 Jan; 40(1):47-9. PubMed ID: 9145611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasmosis: experimental pyelonephritis in rats. The effect of secondary infection with Escherichia coli.
    Thomsen AC; Rosendal S
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Feb; 82(1):94-8. PubMed ID: 4597814
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-coated bacteria in the urinary sediment of rats with experimental pyelonephritis.
    Favaro S; Conventi L; Baggio B; Antonello A; Zanetti M; Zanon GF; Picchi A; Fagiolo U; Borsatti A
    Nephron; 1978; 21(3):165-9. PubMed ID: 353576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afebrile emphysematous pyelonephritis.
    Chung SD
    Int J Infect Dis; 2008 Nov; 12(6):e161. PubMed ID: 18550410
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental hematogenous pyelonephritis due to Escherichia coli in rabbits: the antibody response and its protective capacity.
    Kaijser B; Olling S
    J Infect Dis; 1973 Jul; 128(1):41-9. PubMed ID: 4577974
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental ascending E. coli infection of kidneys in the rat.
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Physiol Bohemoslov; 1969; 18(2):167-75. PubMed ID: 4243168
    [No Abstract]   [Full Text] [Related]  

  • 14. Emphysematous pyelonephritis - case report and evaluation of radiological features.
    Mongha R; Punit B; Ranjit DK; Anup KK
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):838-41. PubMed ID: 19736485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of renal E. coli inoculation on the production of hypertonic urine in rats (author's transl)].
    Bohdanecká M; Prát V; Schück O
    Cas Lek Cesk; 1977 Apr; 116(16):488-90. PubMed ID: 326406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Susceptibility of the solitary, hypertrophied kidney following unilateral nephrectomy to the so-called ascending Coli pyelonephritis in the white rat].
    Tra LN; Seipelt H; Grossmann P; Hilgenfeld E; Hagemann I; Ditscherlein G
    Z Urol Nephrol; 1975 Mar; 68(3):205-12. PubMed ID: 775850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kidney function and bacteriological and histological research in the therapy of experimental E. coli pyelonephritis using trimethoprim-sulfamethoxazole (TMP-SMO)].
    Hagemann I; Briedigkeit H; Strangfeld D; Precht K; Ditscherlein G; Puls U; Neubrandt C; Pietsch R; Kruse I
    Z Urol Nephrol; 1985 Dec; 78(12):681-8. PubMed ID: 3913223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mechanism of P-fimbriated Escherichia coli virulence in pyelonephritis.
    Stapleton A
    J Am Soc Nephrol; 2005 Dec; 16(12):3458-60. PubMed ID: 16280466
    [No Abstract]   [Full Text] [Related]  

  • 19. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model.
    Isling LK; Aalbæk B; Birck MM; Heegaard PM; Leifsson PS
    J Comp Pathol; 2011 May; 144(4):257-68. PubMed ID: 21159351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.